Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Meeting, 79595-79596 [2015-32035]
Download as PDF
<![CDATA[
Federal Register / Vol. 80, No. 245 / Tuesday, December 22, 2015 / Notices
ACTION:
Notice.
This is a notice, in accordance
with 35 U.S.C. 209 and 37 CFR 404, that
the National Institute of Drug Abuse,
National Institutes of Health,
Department of Health and Human
Services is contemplating the grant of an
exclusive start-up option license to
practice the inventions embodied in the
following Patent Applications and all
related continuing and foreign patents/
patent applications for the technology
family to EncepHeal Therapeutics, Inc.,
located in Winston-Salem, North
Carolina.
DATES: Only written comments and/or
applications for a license which are
received by the NCI Technology
Transfer Center on or before January 6,
2016 will be considered.
ADDRESSES: Requests for copies of the
patent application, inquiries, comments,
and other materials relating to the
contemplated exclusive license should
be directed to Martha Lubet, Ph.D.,
Technology Transfer Specialist, NCI
TTC, 9609 Medical Center Drive, Room
IE350, and Rockville, MD 20850.
Telephone: (240) 276–5508. Facsimile:
(240) 276–5505. Email: lubetm@
mail.nih.gov.
SUPPLEMENTARY INFORMATION: This
invention concerns analogues of
modafinil and methods of using the
analogues for the treatment of substance
use disorders and sleep disorders.
The prospective exclusive start-up
option license will be royalty bearing
and will comply with the terms and
conditions of 35 U.S.C. 209 and 37 CFR
part 404. The prospective exclusive
start-up option may be granted unless
within fifteen (15) days from the date of
this published notice, the NCI receives
written evidence and argument that
establishes that the grant of the license
would not be consistent with the
requirements of 35 U.S.C. 209 and 37
CFR part 404.
Complete applications for a license in
the field of use filed in response to this
notice will be treated as objections to
the grant of the contemplated exclusive
start-up option license. Comments and
objections submitted to this notice will
not be made available for public
inspection and, to the extent permitted
by law, will not be released under the
Freedom of Information Act, 5 U.S.C.
552.
Intellectual Property:
U.S. provisional application 61/
774,878, filed March 8, 2013 entitled
‘‘Potent and Selective Inhibitors of
Monamine Transporters; Methods of
Making; and Uses Thereof’’ [HHS Ref.
No. E–073–2013/0–US–01];
mstockstill on DSK4VPTVN1PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:21 Dec 21, 2015
Jkt 238001
PCT application PCT/US2014/021514,
filed March 7, 2014 entitled ‘‘Potent and
Selective Analogues of: Monamine
Transporters; Methods of Making; and
Uses Thereof’’ [HHS Ref. No. E–073–
2013/0–PCT–02];
U.S. application 14/772,486, filed
September 3, 2015 entitled ‘‘Potent and
Selective Analogues of Monamine
Transporters; Methods of Making; and
Uses Thereof’’ [HHS Ref. No. E–073–
2013/0–US–06];
EPO application 14714043.8, filed
September 1, 2015 entitled ‘‘Potent and
Selective Analogues of Monamine
Transporters; Methods of Making; and
Uses Thereof’’ [HHS Ref. No. E–073–
2013/0–EP–05];
Australian application 2014225550,
filed September 8, 2015 entitled ‘‘Potent
and Selective Analogues of Monamine
Transporters; Methods of Making; and
Uses Thereof’’ [HHS Ref. No. E–073–
2013/0–AU–03];
Canadian application 2903746, filed
September 2, 2015 entitled ‘‘Potent and
Selective Analogues of Monamine
Transporters; Methods of Making; and
Uses Thereof’’ [HHS Ref. No. E–073–
2013/0–CA–04];
The patent rights to these inventions
have been assigned to and/or
exclusively licensed to the Government
of the United States of America.
The prospective exclusive start-up
option licensed territory may be
worldwide and the field of use may be
limited to: (a) Treatment of substance
use disorders and/or (b) treatment of
sleep disorders.
Upon the expiration or termination of
the exclusive start-up option license,
EncepHeal Therapeutics, Inc. will have
the exclusive right to execute a start-up
exclusive commercialization license
which will supersede and replace the
exclusive start-up option license with
no greater field of use and territory than
granted in the exclusive start-up option
license.
Dated: December 17, 2015.
Richard U. Rodriguez,
Associate Director, Technology Transfer
Center, National Cancer Institute.
[FR Doc. 2015–32141 Filed 12–21–15; 8:45 am]
79595
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Initial Review Group; Clinical Aging
Review Committee.
Date: February 4–5, 2016.
Time: 2:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott and
Conference Center, 5701 Marinelli Road,
Bethesda, MD 20852.
Contact Person: Alicja L. Markowska,
Ph.D., DSC, National Institute on Aging,
National Institutes of Health, Gateway
Building 2C212, 7201 Wisconsin Avenue,
Bethesda, MD 20892, 301–496–9666
markowsa@nia.nih.gov.
Name of Committee: National Institute on
Aging Initial Review Group; Biological Aging
Review Committee.
Date: February 4–5, 2016.
Time: 2:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott and
Conference Center, 5701 Marinelli Road,
Bethesda, MD 20852.
Contact Person: Bita Nakhai, Ph.D.,
Scientific Review Branch, National Institute
on Aging, Gateway Bldg., 2C212, 7201
Wisconsin Avenue, Bethesda, MD 20814,
301–402–7701, nakhaib@nia.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: December 16, 2015.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–32036 Filed 12–21–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4140–01–P
National Institutes of Health
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Eunice Kennedy Shriver National
Institute of Child Health & Human
Development; Notice of Meeting
National Institutes of Health
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
National Advisory Child Health and
Human Development Council.
National Institute on Aging; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
E:\FR\FM\22DEN1.SGM
22DEN1
79596
Federal Register / Vol. 80, No. 245 / Tuesday, December 22, 2015 / Notices
The meeting will be open to the
public as indicated below, with
attendance limited to space available. A
portion of this meeting will be closed to
the public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended for the review and
discussion of grant applications.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the contact person listed below in
advance of the meeting.
mstockstill on DSK4VPTVN1PROD with NOTICES
Name of Committee: National Advisory
Child Health and Human Development
Council.
Date: January 21, 2016.
Open: January 21, 2016, 8:00 a.m. to 1:00
p.m.
Date: January 21, 2016.
Closed: January 21, 2016, 1:45 p.m. to
Adjournment.
Agenda: Report of the Director, NICHD;
Division of Extramural Research Report;
Precision Medicine Initiative Presentation;
Legislation 101 and Funding the Best
Science.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, Center Drive, C-Wing,
Conference Room 6, Bethesda, MD 20892.
Contact Person: Della Hann, Ph.D.,
Director, Division of Extramural Research,
Eunice Kenney Shriver National Institute of
Child Health and Human Development, NIH,
6100 Executive Blvd., Room 4A05, MSC
7510, Bethesda, MD 20892, (301) 496–5577.
Any interested person may file written
comments with the committee by forwarding
the statement to the contact person listed on
this notice. The statement should include the
name, address, telephone number, and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxis, hotel, and airport shuttles,
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
In order to facilitate public attendance at
the open session of Council in the main
meeting room, Conference Room 6, please
contact Ms. Lisa Kaeser, Program and Public
Liaison Office, NICHD, at 301–496–0536 to
make your reservation, additional seating
will be available in the meeting overflow
rooms, Conference Rooms 7 and 8.
Individuals will also be able to view the
meeting via NIH Videocast. Please go to the
VerDate Sep<11>2014
17:21 Dec 21, 2015
Jkt 238001
following link for Videocast access
instructions at: https://www.nichd.nih.gov/
about/advisory/nachhd/Pages/virtualmeeting.aspx.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment program, National
Institutes of Health, HHS).
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
information on the proposed project
contact: Mary Anne Bright, NCI Office
of Communications and Public Liaison,
9609 Medical Center Drive, Rockville,
MD 20850 or call non-toll-free number
240–276–6647 or Email your request,
including your address to: brightma@
mail.nih.gov. Formal requests for
additional plans and instruments must
be requested in writing.
Direct Comments to OMB: Written
comments and/or suggestions regarding
the item(s) contained in this notice,
especially regarding the estimated
public burden and associated response
time, should be directed to the: Office
of Management and Budget, Office of
Regulatory Affairs, OIRA_submission@
omb.eop.gov or by fax to 202–395–6974,
Attention: NIH Desk Officer.
National Institutes of Health
SUPPLEMENTARY INFORMATION:
Dated: December 16, 2015.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–32035 Filed 12–21–15; 8:45 am]
BILLING CODE 4140–01–P
Submission for OMB review; 30-Day
Comment Request; Collection of
Customer Service, Demographic, and
Smoking/Tobacco Use Information
From the National Cancer Institute’s
Cancer Information Service (CIS)
Clients (NCI)
Under the provisions of
Section 3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National
Cancer Institute (NCI), the National
Institutes of Health (NIH), has submitted
to the Office of Management and Budget
(OMB) a request for review and
approval of the information collection
listed below. This proposed information
collection was previously published in
the Federal Register on September 28,
2015, Vol. 80, page 58268 and allowed
60-days for public comment. One public
comment was received. The purpose of
this notice is to allow an additional 30
days for public comment. The National
Cancer Institute (NCI), National
Institutes of Health, may not conduct or
sponsor, and the respondent is not
required to respond to, an information
collection that has been extended,
revised, or implemented on or after
October 1, 1995, unless it displays a
currently valid OMB control number.
DATES: Comment Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 30-days of the date of
this publication.
FOR FURTHER INFORMATION CONTACT: To
obtain a copy of the data collection
plans and instruments or request more
SUMMARY:
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
Proposed Collection: Collection of
Customer Service, Demographic, and
Smoking/Tobacco use Information from
the National Cancer Institute’s Cancer
Information Service (CIS) Clients (NCI),
0925–0208, Expiration Date December
31, 2015, Revision, National Cancer
Institute (NCI), National Institute of
Health (NIH).
Need and Use of Information
Collection. The National Cancer
Institute (NCI) currently collects: (1)
Customer service and demographic
information from clients of the Cancer
Information Service (CIS) in order to
properly plan, implement, and evaluate
cancer education efforts, including
assessing the extent by which the CIS
reaches and impacts underserved
populations; (2) smoking/tobacco use
behavior of individuals seeking NCI’s
smoking cessation assistance through
the CIS in order to provide smoking
cessation services tailored to the
individual client’s needs and track their
smoking behavior at follow up. This is
a request for OMB to approve a revised
submission for an additional three years
to provide ongoing customer service
collection of demographic information,
and collection of brief customer
satisfaction questions from NCI Cancer
Information Service (CIS) Clients for the
purpose of program planning and
evaluation.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
3,387.
E:\FR\FM\22DEN1.SGM
22DEN1
]]>Agencies
[Federal Register Volume 80, Number 245 (Tuesday, December 22, 2015)]
[Notices]
[Pages 79595-79596]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-32035]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Eunice Kennedy Shriver National Institute of Child Health & Human
Development; Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of a meeting of the
National Advisory Child Health and Human Development Council.
[[Page 79596]]
The meeting will be open to the public as indicated below, with
attendance limited to space available. A portion of this meeting will
be closed to the public in accordance with the provisions set forth in
sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended for the
review and discussion of grant applications. Individuals who plan to
attend and need special assistance, such as sign language
interpretation or other reasonable accommodations, should notify the
contact person listed below in advance of the meeting.
Name of Committee: National Advisory Child Health and Human
Development Council.
Date: January 21, 2016.
Open: January 21, 2016, 8:00 a.m. to 1:00 p.m.
Date: January 21, 2016.
Closed: January 21, 2016, 1:45 p.m. to Adjournment.
Agenda: Report of the Director, NICHD; Division of Extramural
Research Report; Precision Medicine Initiative Presentation;
Legislation 101 and Funding the Best Science.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Building 31, Center Drive,
C-Wing, Conference Room 6, Bethesda, MD 20892.
Contact Person: Della Hann, Ph.D., Director, Division of
Extramural Research, Eunice Kenney Shriver National Institute of
Child Health and Human Development, NIH, 6100 Executive Blvd., Room
4A05, MSC 7510, Bethesda, MD 20892, (301) 496-5577.
Any interested person may file written comments with the
committee by forwarding the statement to the contact person listed
on this notice. The statement should include the name, address,
telephone number, and when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxis, hotel, and airport shuttles, will be inspected
before being allowed on campus. Visitors will be asked to show one
form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their
visit.
In order to facilitate public attendance at the open session of
Council in the main meeting room, Conference Room 6, please contact
Ms. Lisa Kaeser, Program and Public Liaison Office, NICHD, at 301-
496-0536 to make your reservation, additional seating will be
available in the meeting overflow rooms, Conference Rooms 7 and 8.
Individuals will also be able to view the meeting via NIH Videocast.
Please go to the following link for Videocast access instructions
at: https://www.nichd.nih.gov/about/advisory/nachhd/Pages/virtual-meeting.aspx.
(Catalogue of Federal Domestic Assistance Program Nos. 93.864,
Population Research; 93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation Research; 93.209,
Contraception and Infertility Loan Repayment program, National
Institutes of Health, HHS).
Dated: December 16, 2015.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-32035 Filed 12-21-15; 8:45 am]
BILLING CODE 4140-01-P
